[131I]-META-IODOBENZYLGUANIDINE IN TREATMENT OF MALIGNANT PHAEOCHROMOCYTOMAS

H Vetter; Manfred M. Fischer; R Müller-Rensing; W. Vetter; B Winterberg

doi:10.1016/s0140-6736(83)90091-0

Related publications

Letter1984

SCINTIGRAPHIC IMAGING OF CARCINOID TUMOURS WITH 131I-METAIODOBENZYLGUANIDINE

Manfred M. Fischer, D. Kamanabroo, H Sonderkamp, Thomas Proske

The Lancet

Article2017

Peripheral Alterations in Cytokine and Chemokine Levels After Antidepressant Drug Treatment for Major Depressive Disorder: Systematic Review and Meta-Analysis

Cristiano A. Köhler, Thiago Holanda Freitas, Brendon Stubbs, Michael Maes, Marco Solmi, Nicola Veronese, Nayanna Quezado de Andrade, Gerwyn Morris, Brisa S. Fernandes, André R. Brunoni, Nathan Herrmann, Charles L. Raison, Brian J. Miller, Krista L. Lanctôt, André F. Carvalho

Molecular Neurobiology

Article2022

We know this much is (meta-analytically) true: A meta-review of meta-analytic findings evaluating self-determination theory.

Richard M. Ryan, Jasper J. Duineveld, Stefano I. Di Domenico, William S. Ryan, Ben Albert Steward, Emma L Bradshaw

Psychological Bulletin

Chapter in a book2024

Radioiodine-Labeled Meta-Iodobenzylguanidine for Imaging and Treatment of Pheochromocytoma/Paraganglioma and Neuroblastoma

Manfred M. Fischer, Matthias Schmidt

Article1994

Preliminary evidence that overexpression of nuclear factor for IL6 expression (NF-IL6) in NIH3T3 cells may be related to malignant transformation

Min‐Sheng Zhu, Ding-Gan Liu, Akira Shizuo, Zai-Ping Li

Cell Research